Patents by Inventor Gerardus Cornelis Maria Selten

Gerardus Cornelis Maria Selten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8067157
    Abstract: Methods are provided for isolation of DNA sequences encoding proteins with properties of interest by means of expression cloning in filamentous fungal host cells. The isolated DNA sequences are useful in processes for producing the proteins of interest.
    Type: Grant
    Filed: February 20, 2007
    Date of Patent: November 29, 2011
    Assignee: DSM IP Assets B.V.
    Inventors: Johannes Maarten Van Den Brink, Gerardus Cornelis Maria Selten, Johannes Petrus Theodorus Wilhelmus Van Den Hombergh
  • Publication number: 20080009006
    Abstract: Methods are provided for isolation of DNA sequences encoding proteins with properties of interest by means of expression cloning in filamentous fungal host cells. The isolated DNA sequences are useful in processes for producing the proteins of interest.
    Type: Application
    Filed: February 20, 2007
    Publication date: January 10, 2008
    Applicant: DSM N.V.
    Inventors: Johannes Maarten Van Den Brink, Gerardus Cornelis Maria Selten, Johannes Petrus Theodorus Wilhelmus Van Den Hombergh
  • Patent number: 7220542
    Abstract: Methods are provided for isolation of DNA sequences encoding proteins with properties of interest by means of expression cloning in filamentous fungal host cells. The isolated DNA sequences are useful in processes for producing the proteins of interest.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: May 22, 2007
    Inventors: Johannes Maarten Van Den Brink, Gerardus Cornelis Maria Selten, Johannes Petrus Theodorus Wilhelmus Van Den Hombergh
  • Patent number: 6955909
    Abstract: The present invention discloses a selection marker free system which can be used to introduce genetic modifications to in bacteria, yeasts and fungi. The system can be employed to introduce or delete desired genes or DNA fragments in the genome of the indicated host species without leaving any undesired DNA i.e. the selection marker used for selection of transformants or other DNA used for cloning. In this way strains have been developed containing only desired genes introduced at desired chromosomal sites. Similarly, desired DNA fragments have been deleted or replaced at desired sites.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: October 18, 2005
    Assignee: DSM N.V.
    Inventors: Gerardus Cornelis Maria Selten, Bart Willem Swinkels, Robertus Franciscus Maria Van Gorcom
  • Publication number: 20040241647
    Abstract: Methods are provided for isolation of DNA sequences encoding proteins with properties of interest by means of expression cloning in filamentous fungal host cells. The isolated DNA sequences are useful in processes for producing the proteins of interest.
    Type: Application
    Filed: April 4, 2002
    Publication date: December 2, 2004
    Applicant: DSM N.V.
    Inventors: Johannes Maarten Van Den Brink, Gerardus Cornelis Maria Selten, Johannes Petrus Theodorus Wilhelmus Van Den Hombergh
  • Publication number: 20040067579
    Abstract: An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins, of catalyzing an oxidation step in the biological pathway for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting of:
    Type: Application
    Filed: June 16, 2003
    Publication date: April 8, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Herman Slijkhuis, Eric Bastiaan Smaal, Gerardus Cornelis Maria Selten
  • Patent number: 6632633
    Abstract: An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins of catalyzing an oxidation step in the biological pathway, for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting of: the conversion of cholesterol to pregnenolone; the conversion of pregnenolone to progesterone; the conversion of progesterone to 17&agr;-hydroxyprogesterone; the conversion of 17&agr;-hydroxyprogesterone to cortexolone; the conversion of cortexolone to hydrocortisone, and the corresponding control sequences effective in that host.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: October 14, 2003
    Assignee: Aventis Pharma, S.A.
    Inventors: Herman Slijkhuis, Eric Bastiaan Smaal, Gerardus Cornelis Maria Selten
  • Publication number: 20030108982
    Abstract: An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins, of catalyzing an oxidation step in the biological pathway for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting a of:
    Type: Application
    Filed: February 26, 2002
    Publication date: June 12, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Herman Slijkhuis, Eric Bastiaan Smaal, Gerardus Cornelis Maria Selten
  • Publication number: 20020155536
    Abstract: Methods are provided for isolation of DNA sequences encoding proteins with properties of interest by means of expression cloning in filamentous fungal host cells. The isolated DNA sequences are useful in processes for producing the proteins of interest.
    Type: Application
    Filed: November 5, 2001
    Publication date: October 24, 2002
    Inventors: Johannes Maarten Van Den Brink, Gerardus Cornelis Maria Selten, Johannes Petrus Theodorus Wilhelmus Van Den Hombergh
  • Patent number: 6432672
    Abstract: The present invention relates to filamentous fungi that comprise in their genomes at least two substantially homologous DNA domains which are suitable for integration of one or more copies of a recombinant DNA molecule and wherein at least two of these DNA domains comprise an integrated copy of a recombinant DNA molecule. The invention also relates to methods for preparing such filamentous fungi and for further multiplying the DNA domains with integrated recombinant DNA molecules through gene conversion or amplification.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: August 13, 2002
    Inventors: Gerardus Cornelis Maria Selten, Bart Willem Swinkels, Roelof Ary Lans Bovenberg
  • Patent number: 6171836
    Abstract: An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins, of catalyzing an oxidation step in the biological pathway for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting of: the conversion of cholesterol to pregnenolone; the conversion of pregnenolone to progesterone; the conversion of progesterone to 17&agr;-hydroxyprogesterone; the conversion of 17&agr;-hydroxyprogesterone to cortexolone; the conversion of cortexolone to hydrocortisone, and the corresponding control sequences effective in said host.
    Type: Grant
    Filed: June 17, 1998
    Date of Patent: January 9, 2001
    Assignee: Hoechst Marion Roussel
    Inventors: Herman Slijkhuis, Eric Bastiaan Smaal, Gerardus Cornelis Maria Selten
  • Patent number: 5869283
    Abstract: An expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein, which is functional, alone or in cooperation with one or more additional proteins, of catalyzing an oxidation step in the biological pathway for conversion of cholesterol into hydrocortisone, which step is selected from the group consisting of:the conversion of cholesterol to pregnenolone;the conversion of pregnenolone to progesterone;the conversion of progesterone to 17.alpha.-hydroxy-progesterone;the conversion of 17.alpha.-hydroxyprogesterone to cortexolone;the conversion of cortexolone to hydrocortisone, and thecorresponding control sequences effective in said host.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: February 9, 1999
    Assignee: Roussel Uclaf
    Inventors: Herman Slijkhuis, Eric Bastiaan Smaal, Gerardus Cornelis Maria Selten